(19)
(11) EP 0 935 654 A1

(12)

(43) Date of publication:
18.08.1999 Bulletin 1999/33

(21) Application number: 97916166.0

(22) Date of filing: 21.03.1997
(51) International Patent Classification (IPC): 
C12N 15/ 02( . )
A61K 31/ 70( . )
A61K 35/ 76( . )
A61K 49/ 00( . )
A61P 25/ 00( . )
A61P 35/ 00( . )
C07K 16/ 22( . )
C12N 1/ 19( . )
C12N 5/ 10( . )
C12N 15/ 12( . )
C12P 21/ 08( . )
A61K 31/ 00( . )
A61K 31/ 7088( . )
A61K 48/ 00( . )
A61K 51/ 00( . )
A61P 25/ 02( . )
C07K 14/ 50( . )
C12N 1/ 15( . )
C12N 1/ 21( . )
C12N 15/ 09( . )
C12P 21/ 02( . )
A61K 38/ 00( . )
(86) International application number:
PCT/US1997/004641
(87) International publication number:
WO 1997/035007 (25.09.1997 Gazette 1997/41)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 21.03.1996 US 19960621143

(71) Applicant: THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
Baltimore, MD 21205 (US)

(72) Inventors:
  • NATHANS, Jeremy
    Baltimore, MD 21209 (US)
  • SMALLWOOD, Philip, M.
    Woodbine, MD 21797-9621 (US)
  • TONG, Patrick
    Baltimore, MD 21210-1522 (US)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTOR-3 (FHF-3) AND METHODS OF USE